VLT-015

· CF Pharma, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VLT-015, covering 2024-08-21 to 2024-08-21. Get the full timeline:

Most recent: Clinical Trial Update: VLT-015 in Patients With Schizophrenia [Phase 1]